Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial

PFE: Pfizer Inc.
2021-08-04 06:45:00
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata